Clinical Trial Update: ALPs Single ChambEr New Device [NA]

View source ↗

Summary

Cairdac SA's ALPs single-chamber device is being studied for bradycardia, brady-tachycardia syndrome, AV block, and atrial fibrillation, but the trial is not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrioventricular Block
• Brady-tachycardia Syndrome
• Bradycardia

Snippet

Sponsor: Cairdac SA | Conditions: Bradycardia, Brady-tachy Syndrome | NA | Status: NOT_YET_RECRUITING